ML43702: Long-Term Follow-Up Study Of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment

Grants and Contracts Details

StatusActive
Effective start/end date2/22/23 → 2/22/25

Funding

  • Genentech Inc: $1,253.00